nov 2017 hepatitis c gt3a lipid HCV Replicon Systems: Workhorses of Drug Discovery and Resistance Infection with the hepatitis C

e , f , KRAS G12D inhibitor MRTX1133 reduced Smurf1 protein ( e ) and mRNA ( f ) levels in KRAS G12D mutant HCT116 cells (n = 4 technical repeats from one of three independent experiments)

The anti-GAD antibodies may also act on nerve terminals of GABAergic interneurons depressing the release of GABA resulting in neuronal hyperexcitability but, whether this process can eventually disturb the function of Purkinje cells, as proposed [65, 66], remains hypothetical

Additionally, we thank our colleagues for their valuable suggestions and insightful discussions during the preparation of this review

I think that it should be done, honestly, because it's a low hanging fruit